Arnet, L.; Emilius, L.; Hamann, A.; Carmo-Fonseca, M.; Berking, C.; Dörrie, J.; Schaft, N.
The Influence of Indisulam on Human Immune Effector Cells: Is a Combination with Immunotherapy Feasible? Pharmaceutics 2025, 17, 368.
https://doi.org/10.3390/pharmaceutics17030368
AMA Style
Arnet L, Emilius L, Hamann A, Carmo-Fonseca M, Berking C, Dörrie J, Schaft N.
The Influence of Indisulam on Human Immune Effector Cells: Is a Combination with Immunotherapy Feasible? Pharmaceutics. 2025; 17(3):368.
https://doi.org/10.3390/pharmaceutics17030368
Chicago/Turabian Style
Arnet, Lisa, Lisabeth Emilius, Annett Hamann, Maria Carmo-Fonseca, Carola Berking, Jan Dörrie, and Niels Schaft.
2025. "The Influence of Indisulam on Human Immune Effector Cells: Is a Combination with Immunotherapy Feasible?" Pharmaceutics 17, no. 3: 368.
https://doi.org/10.3390/pharmaceutics17030368
APA Style
Arnet, L., Emilius, L., Hamann, A., Carmo-Fonseca, M., Berking, C., Dörrie, J., & Schaft, N.
(2025). The Influence of Indisulam on Human Immune Effector Cells: Is a Combination with Immunotherapy Feasible? Pharmaceutics, 17(3), 368.
https://doi.org/10.3390/pharmaceutics17030368